Karalicin

Karalicin inhibits herpes simplex virus HSV-1, HSV-2, vaccinia virus, polio virus type I with the IC50s (μg/mL) of 0.004, 0.008, 0.016 and 0.016[1].

Product Specifications

CAS Number

[175413-72-6]

UNSPSC

12352005

Target

HSV

Related Pathways

Anti-infection

Applications

COVID-19-anti-virus

Field of Research

Infection

Smiles

O=C(C)OC(C(CC1=CC=C(C=C1)OC)O)C(CO)O

Molecular Formula

C14H20O6

Molecular Weight

284.31

References & Citations

[1]G Lampis, et al. Karalicin, a new biologically active compound from Pseudomonas fluorescens/putida. II. Biological properties. J Antibiot (Tokyo) . 1996 Mar;49 (3) :263-6.

Shipping Conditions

Room temperature

Scientific Category

Natural Products

Clinical Information

No Development Reported

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

MBS9229292-01 0.5 mg

FATE1 Blocking Peptide (Center)

Ask

View Details

MBS9229292-02 5x 0.5 mg

FATE1 Blocking Peptide (Center)

Ask

View Details

bs-42061R-BF594 100 µL

CTRC Polyclonal Antibody, AbBy Fluor™ 594 Conjugated

Ask

View Details

GTR15315693 1 Vial

Lentiviral human C5orf63 shRNA (UAS) - Lentiviral human C5orf63 shRNA (UAS) (100)

Ask

View Details

MBS1342701-01 0.02 mg (E-Coli)

Recombinant Cryptococcus gattii Superoxide dismutase [Cu-Zn] (SOD1)

Ask

View Details

MBS1342701-02 0.1 mg (E-Coli)

Recombinant Cryptococcus gattii Superoxide dismutase [Cu-Zn] (SOD1)

Ask

View Details